A new engineering strategy for improving the biosynthesis of secondary metabolites in Streptomyces has been developed through the analysis of genes co-evolved with biosynthetic gene clusters. This strategy has been verified in 11 Streptomyces strains to enhance production of 16,385 metabolites, showing potential applications in drug discovery and industrial production.
This is a preview of subscription content, log in via an institution to check access.
References
Gavriilidou, A. et al. Compendium of specialized metabolite biosynthetic diversity encoded in bacterial genomes. Nat. Microbiol. 7, 726–735 (2022). This paper reports secondary metabolite biosynthetic diversity in bacteria.
Challis, G. L. & Hopwood, D. A. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc. Natl Acad. Sci. USA 100 (Suppl. 2), 14555–14561 (2003). This review discusses the idea that synergy drives evolution of multiple secondary metabolite BGCs contributing to host competitiveness.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Wang, X. et al. Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis. Nat. Metab. https://doi.org/10.1038/s42255-024-01024-9 (2024).
Rights and permissions
About this article
Cite this article
Co-evolved genes improve the biosynthesis of secondary metabolites. Nat Metab (2024). https://doi.org/10.1038/s42255-024-01035-6
Published:
DOI: https://doi.org/10.1038/s42255-024-01035-6
- Springer Nature Limited